QVIS is a Korea-based quality assurance and pharmacovigilance specialist founded in 2014 as Korea’s first clinical trial quality assurance company. We provide integrated Quality Management, Pharmacovigilance, and Project Management services, including risk-based QM, GCP/GCLP/GVP audits, vendor qualification, SOP development, CAPA management, mock inspections, clinical and post-marketing PV, ICSR processing, literature monitoring, RMP/PBRER/PSUR writing, SDEA support, and regulatory reporting. Trusted by 250+ pharmaceutical and biotech companies, QVIS supports projects across Korea, Asia, the U.S., and Europe. QVIS has also established a cross-border collaboration model to support European companies entering Korea and Asia, and Korean companies expanding into Europe, by connecting local execution, PV, quality management, regulatory safety, audit, and inspection-readiness capabilities through its global partner network.